✨
AI Summary
- Philina Lee discusses lead-based targeted alpha therapies for deeper cancer responses.
- AdvanCell's $315M Series D raise highlights manufacturing importance and vertical integration.
- Future plans include a regional U.S. manufacturing network for radiopharmaceuticals.
Guests on This Episode
PP
Philina Lee, Ph.D
1 podcast appearance